CompletedPhase 2

Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker

Egypt40 participantsStarted 2020-01-11

Plain-language summary

Aim of work: To evaluate the effect of stellate ganglion block in prevention of cerebrovascular spasm in traumatic subarachnoid hemorrhage Primary outcome: Asses changes of cerebral blood flow velocity by Trans cranial Doppler. Secondary outcome: Asses changes in clinical status

Who can participate

Age range16 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ASA: I, II
✓. Head trauma
✓. Hemodynamically stable patient
✓. Mechanically ventilated or not
✓. SAH diagnosed by CT brain

Exclusion criteria

✕. relative refusal.
✕. allergy to local anesthetic.
✕. Any coagulation disorder.
✕. Any vascular disease.
✕. Penetrating head trauma.
✕. Poly traumatized patient.

What they're measuring

cerebral blood flow velocity

Timeframe: From 10 minutes to 24 hour after block

Trial details

NCT IDNCT04100824

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-11

View on ClinicalTrials.gov More Subarachnoid Hemorrhage trials